- Home
- OPRX
as 05-30-2025 4:00pm EST
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 154.9M | IPO Year: | N/A |
| Target Price: | $10.38 | AVG Volume (30 days): | 329.8K |
| Analyst Decision: | Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.84 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.78 - $12.78 | Next Earning Date: | 05-12-2025 |
| Revenue: | $94,365,000 | Revenue Growth: | 20.66% |
| Revenue Growth (this year): | 13.85% | Revenue Growth (next year): | 11.15% |
Stock Insider Trading Activity of OptimizeRx Corporation (OPRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lang James Paul | OPRX | Director | Mar 14 '25 | Buy | $7.60 | 321,408 | $2,443,761.45 | 389,452 |
Latest OptimizeRx Corporation News
OPRX Breaking Stock News: Dive into OPRX Ticker-Specific Updates for Smart Investing
Zacks
9 days ago
Earnings Estimates Rising for OptimizeRx (OPRX): Will It Gain?
GlobeNewswire
16 days ago
OptimizeRx to Participate in Upcoming Investor Conferences
Simply Wall St.
18 days ago
OptimizeRx First Quarter 2025 Earnings: Beats Expectations
Thomson Reuters StreetEvents
19 days ago
Q1 2025 OptimizeRx Corp Earnings Call
GuruFocus.com
19 days ago
OptimizeRx Corp (OPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
Zacks
19 days ago
OptimizeRx Corp. (OPRX) Beats Q1 Earnings and Revenue Estimates
GlobeNewswire
19 days ago
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
GuruFocus.com
22 days ago
Earnings To Watch: OptimizeRx Corp (OPRX) Reports Q1 2025 Result
Compare OPRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "OPRX OptimizeRx Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.